The Beauty Health Company (NASDAQ: SKIN) reported Q4 EPS of ($0.06), $0.01 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $82.4 million versus the consensus estimate of $77.73 million.

For earnings history and earnings-related data on The Beauty Health Company (SKIN) click here.